News
GlobalData on MSN10d
Eli Lilly and GSK drive South Korea’s drug licensing activity
South Korea’s pharma industry has a valuable pool of promising drugs, but China still leads the way in out-licensing deals.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback